This inventor holds 4 USPTO granted patents and 10 published patent applications and 1 EPO patent. Top assignee: Obsidian Therapeutics, Inc.. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: The Innovative Contributions of Mara Christine Inniss
Introduction
Mara Christine Inniss is a prominent inventor based in Beverly, MA (US). She has made significant contributions to the field of biotechnology, particularly in the area of protein regulation and immunotherapy. With a total of 4 patents to her name, Inniss is recognized for her innovative approaches to complex biological challenges.
Latest Patents
Among her latest patents, Inniss has developed a technology related to DHFR tunable protein regulation. This invention focuses on compositions and methods for the regulated and controlled expression of proteins. Additionally, she has worked on PDE5 compositions and methods for immunotherapy, which relate to inducing anti-cancer immune responses in subjects. These advancements highlight her commitment to improving therapeutic strategies in medicine.
Career Highlights
Mara Christine Inniss has established herself as a key figure in her field through her work at Obsidian Therapeutics, Inc. Her role at the company allows her to collaborate with other talented professionals and contribute to groundbreaking research. Her innovative spirit and dedication to her work have positioned her as a leader in biotechnology.
Collaborations
Inniss has collaborated with notable colleagues such as Vipin Suri and Byron Delabarre. These partnerships have enabled her to enhance her research and expand the impact of her inventions.
Conclusion
Mara Christine Inniss exemplifies the spirit of innovation in biotechnology through her patents and contributions to protein regulation and immunotherapy. Her work continues to inspire advancements in medical science and showcases the importance of collaboration in achieving groundbreaking results.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile